Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$71.33BHealthcare Market cap, Sector
Zimmer Biomet Holdings
ZBH$16.86BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 70 ZBH
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS7wins
0winsZBH
84B
D54
87A
D51
92A
D49
66C
F38
75B
F26
91A
F44
95A
D48
Side-by-side metrics
| Metric | JSLL.NS | ZBH |
|---|---|---|
| Market cap | Winner: $71.33B | $16.86B |
| P/E (TTM) | 33.3x | 21.4x Winner |
| EV/EBIT | 24.1x | 17.1x Winner |
| ROIC (TTM) | Winner: 39.15% | 4.98% |
| Gross margin | Winner: 88.58% | 70.03% |
| Net margin | Winner: 27.68% | 9.05% |
| Revenue CAGR 5y | Winner: 57.81% | 4.79% |
| EPS CAGR 5y | Winner: 86.67% | 16.54% |
| Debt / Equity | Winner: 0.3x | 0.5x |
| Dividend yield | - | 1.15% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- Revenue CAGR 5y57.81%vs 4.79%+92%
- ROIC (TTM)39.15%vs 4.98%+87%
- EPS CAGR 5y86.67%vs 16.54%+81%
- Market cap$71.33Bvs $16.86B+76%
ZBH leads on
- P/E (TTM)21.4xvs 33.3x+36%
- EV/EBIT17.1xvs 24.1x+29%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.